Discounted Cash Flow (DCF) Analysis Levered

Cardio Diagnostics Holdings, Inc. (CDIO)

$1.81

+0.06 (+3.43%)
All numbers are in Millions, Currency in USD

Free Cash Flow

Year
A/P
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue --------
Revenue (%)
Operating Cash Flow --------
Operating Cash Flow (%)
Capital Expenditure --------
Capital Expenditure (%)
Free Cash Flow --------

Weighted Average Cost Of Capital

Share price $ 1.81
Beta 5.554
Diluted Shares Outstanding 3.09
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt -%
Risk-Free Rate
Market Risk Premium
Cost of Equity 30.500
Total Debt -
Total Equity 5.59
Total Capital -
Debt Weighting -
Equity Weighting -
Wacc

Build Up Free Cash Flow

Year
A/P
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue --------
Operating Cash Flow --------
Capital Expenditure --------
Free Cash Flow --------
WACC
PV LFCF -----
SUM PV LFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -4.12
Equity Value -
Shares Outstanding 3.09
Equity Value Per Share -